Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The Rise of Oral GLP-1 Therapies After injectable GLP-1 therapies set new efficacy standards, industry focus is shifting toward oral delivery
These medications are now being considered for cardiovascular risk reduction in overweight or obese patients with heart disease, regardless of diabetes status
Note: The MM+M Podcast uses speech-recognition software to generate transcripts, which may contain errors
Growth hormone secretagogues (GHSs) and GHRH analogues Agents such as GHRH analogues and ghrelin receptor agonists (e.g., tesamorelin, macimorelin, ipamorelin and related molecules) stimulate endogenous GH release rather than providing recombinant GH itself
US$ 25.58
US$ 20.27
US$ 20.70
